SAFETY AND EFFICACY OF 2mg BULEVIRTIDE IN PATIENTS WITH CHRONIC HBV/HDV CO-INFECTION. FIRST REAL-WORLD RESULTS (FRENCH EARLY ACCESS PROGRAM).
Victor De Ledinghen,Dominique Guyader,Sophie Metivier,Marie-Noelle Hilleret,Helene Fontaine,Bruno Roche,Nathalie Ganne Carrie,Louis D. Alteroche,Veronique Loustaud Ratti,Anne Gervais,Christiane Stern,Laurent Alric,Isabelle Fouchard Hubert,Tarik Asselah,Karine Lacombe,Fabien Zoulim,Jerome Dumortier,Anne Minello Franza,Caroline Lascoux-Combe,Leon Muti,Isabelle Ollivier Hourmand,Dominique Larrey,Vincent Leroy,Isabelle Rosa,Julie Chas,Frederic Heluwaert,Patrick Borentain,Isabelle Archambeaud Mabile,Bernard Prouvost-Keller,Si Nafa Si Ahmed,Dominique Roulot-Marullo HEPATOLOGY(2021)
AI 理解论文
溯源树
样例